Dr. Gordon L. Klein was a co-discoverer of the mechanism by which anti-resorptive agents used to treat osteoporosis can prevent muscle wasting following burns.
GALVESTON, TX, February 18, 2019 /24-7PressRelease/ -- Marquis Who's Who, the world's premier publisher of biographical profiles, is proud to present Gordon L. Klein, MD, with the Albert Nelson Marquis Lifetime Achievement Award. An accomplished listee, Dr. Klein celebrates many years' experience in his professional network, and has been noted for achievements, leadership qualities, and the credentials and successes he has accrued in his field. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.
Dr. Klein has excelled as a senior scientist at Shriners Burns Hospital for the University of Texas Medical Branch at Galveston since 2010, for which he held the post of an adjunct professor of orthopedic surgery since 2018. In addition to his current appointments, he found success with the University of Texas Medical Branch at Galveston as a clinical professor of orthopedic surgery from 2010 to 2017 and a member of the medical staff between 2010 and 2012. Previously, Dr. Klein worked as a professor of pediatrics at the University of Texas Medical Branch at Galveston from 1995 to 2009.
Supported by more than 35 years of experience in medicine and education, Dr. Klein began his career as an adjunct assistant professor of pediatrics at UCLA School of Medicine and clinical associate physician of the UCLA Clinical Research Center on an NIH-funded grant in 1980 before becoming assistant professor of pediatrics and adjunct professor of nutrition at Tulane University School of Medicine (1982-1984). He served as a pediatric gastroenterologist for the City of Hope Medical Center from 1984 to 1986 before relocating to Texas. Dr. Klein also provided his expertise to the University of Kentucky for a short time between 2009 and 2010.
Renowned for his work in the development of the Pediatric Bone Disease Initiative with the American Society for Bone and Mineral Research and the National Institutes of Health, Dr. Klein was also responsible for the development of Food and Drug Administration rule governing aluminum contamination of intravenous solutions used for the nutrition of hospitalized patients. He has conducted collaborative studies with U.S. Army Institute for surgical research on the effects of combat injury on calcium and bone metabolism, introduced bone density determinations into the routine diagnostic management of severely burned children and characterized the toxic damage of aluminum to bones and liver, as well as the bone loss following burn injuries, including abnormalities in vitamin D, calcium, the parathyroid hormone and the prevention of the bone loss. Most recently he was a co-discoverer of the mechanism by which anti-resorptive agents used to treat osteoporosis can prevent muscle wasting following burns. Serving on dozens of committees and involved in multiple conferences both nationally and internationally throughout his career, Dr. Klein has contributed to NIH Working Groups on prioritizing research on the pediatric uses of FDA-approved drugs under the Congressionally-mandated Best Pharmaceuticals for Children Act.
Dr. Klein recently presented research at the 8th and 7th International Conferences on Osteoporosis and Bone Research in Chongqing, China in 2016 and Xiamen, China in 2014 and participated on the science advisory committee as well as presenting research at the 11th and the 10th International Conferences of Bone and Mineral Research in Guangzhou in 2013 and Xian, China in 2012. He also held the position of a visiting professor at numerous institutions, including Okayama University, Kyusha University, the Baylor College of Medicine, the Universities of Sheffield, Cincinnati, and Pittsburgh and has given multiple guest lectures at Harvard, Cambridge and Oxford Universities. Furthermore, Dr. Klein was active as a consultant in malnutrition for the Nicaraguan Ministry of Health (1992), a consultant on aluminum toxicity in infants for the Food and Drug Administration (1998-2006) and a consultant for several private organizations such as Abbott Laboratories (2002) and Novartis (2012).
Writing extensively in his area of expertise, Dr. Klein has authored articles in various peer reviewed journals, served as a peer reviewer for over 50 journals and has been appointed to various journal editorial boards. He has been on the board of the Journal of Bone and Mineral Research (2008-2012), F-1000 Research since 2012 and Osteoporosis and Sarcopenia since 2015. He is also a member of the internationally advisory board of the Journal of Bone and Mineral Metabolism since 2005. A co-editor for several other publications, Dr. Klein was the editor of a book: Bone Drugs in Pediatrics in 2014 (Springer) and guest editor of an issue of Seminars in Cell and Developmental Biology in January 2016.
Recognized as a clinical associate physician by the National Institutes of Health from 1980 to 1982, Dr. Klein was the recipient of a National Research Service Award from 1979 to 1980 and a Commanding General Medallion of Excellence from the Fourth Infantry Division of the United States Army in 2006 for his work on bone loss following burn injury. He was nominated for a Howard Hughes Investigatorship in Translational Research in 2001, and more recently he was conferred an overseas fellowship from the Royal Society of Medicine in London (2017) and membership in the inaugural Fellowship class of the American Society for Bone and Mineral Research (2018). Furthermore, Dr. Klein has been featured in approximately 40 editions of Who's Who, including Who's Who in America, Who's Who in American Education and Who's Who in Science and Engineering.
Earning a bachelor's degree at Columbia University in 1967, Dr. Klein then completed work in Investigative Medicine at the University of Cambridge between 1970 and 1971. He furthered his studies with a Doctor of Medicine at the Albert Einstein College of Medicine in 1971. Continuing his training through an internship and residency in pediatrics at Stanford University Medical Center and the International Center of Medical Research and Training in Colombia, a postdoctoral fellowship in pediatrics nutrition at Johns Hopkins University Medical School and the Nutrition Research Institute and a fellowship in pediatrics gastroenterology at the University of California at Los Angeles, he later completed his academic efforts with a Master of Public Health at the University of California at Los Angeles in 1980. Certified in pediatrics gastroenterology and nutrition through the American Board of Pediatrics, Dr. Klein notably served as a lieutenant commander in the U.S. Navy Medical Corps between 1974 and 1976.
In recognition of outstanding contributions to his profession and the Marquis Who's Who community, Gordon L. Klein, MD, has been featured on the Albert Nelson Marquis Lifetime Achievement website. Please visit www.ltachievers.com for more information about this honor.
About Marquis Who's Who®
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Today, Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. Marquis® now publishes many Who's Who titles, including Who's Who in America®, Who's Who in the World®, Who's Who in American Law®, Who's Who in Medicine and Healthcare®, Who's Who in Science and Engineering®, and Who's Who in Asia®. Marquis® publications may be visited at the official Marquis Who's Who® website at www.marquiswhoswho.com.
# # #